Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuankun Chen

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Trends in Pharmacological Sciences|September 27, 2023
Targeted degradation of extracellular secreted and membrane proteinsXuankun Chen, Yaxian Zhou, Yuan Zhao, et al.
Journal of the American Chemical Society|February 11, 2026
Development of Prostate-Specific Lysosome-Targeting DegradersDeqin Cai, Xuankun Chen, Yaxian Zhou, et al.
Frontiers in Pharmacology|July 18, 2022
The Role of Membrane-Associated E3 Ubiquitin Ligases in CancerXuankun Chen, Li Jiang, Zhesheng Zhou, et al.
Nature Communications|October 8, 2024
Development of folate receptor targeting chimeras for cancer selective degradation of extracellular proteinsYaxian Zhou, Chunrong Li, Xuankun Chen, et al.
European Journal of Medicinal Chemistry|December 5, 2021
Noncovalent CDK12/13 dual inhibitors-based PROTACs degrade CDK12-Cyclin K complex and induce synthetic lethality with PARP inhibitorTian Niu, Kailin Li, Li Jiang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 28, 2026
Potent and Selective IGF-IIR-Recruiting Bifunctional Molecules for Targeted Lysosomal Degradation of Extracellular and Membrane ProteinsYuan Zhao, Yaxian Liao, Pengyun Li, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Trends in Pharmacological Sciences|September 27, 2023
Targeted degradation of extracellular secreted and membrane proteinsXuankun Chen, Yaxian Zhou, Yuan Zhao, et al.
Journal of the American Chemical Society|February 11, 2026
Development of Prostate-Specific Lysosome-Targeting DegradersDeqin Cai, Xuankun Chen, Yaxian Zhou, et al.
Frontiers in Pharmacology|July 18, 2022
The Role of Membrane-Associated E3 Ubiquitin Ligases in CancerXuankun Chen, Li Jiang, Zhesheng Zhou, et al.
Nature Communications|October 8, 2024
Development of folate receptor targeting chimeras for cancer selective degradation of extracellular proteinsYaxian Zhou, Chunrong Li, Xuankun Chen, et al.
European Journal of Medicinal Chemistry|December 5, 2021
Noncovalent CDK12/13 dual inhibitors-based PROTACs degrade CDK12-Cyclin K complex and induce synthetic lethality with PARP inhibitorTian Niu, Kailin Li, Li Jiang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 28, 2026
Potent and Selective IGF-IIR-Recruiting Bifunctional Molecules for Targeted Lysosomal Degradation of Extracellular and Membrane ProteinsYuan Zhao, Yaxian Liao, Pengyun Li, et al.
Pageof 1